| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |